Mepolizumab is an immunomodulator used to treat severe asthma and hypereosinophilic syndrome. It works by inhibiting interleukin-5 (IL-5), a key cytokine in eosinophil growth and activation. This medication is crucial for controlling asthma symptoms and managing eosinophilic disorders. In summary, Mepolizumab is effective in treating severe asthma and related conditions.
Mepolizumab binds to IL-5, preventing it from interacting with its receptor on eosinophils, thereby reducing eosinophil levels and associated inflammation.